Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancerSIDDIQUI, G. K; MACLEAN, A. B; ELMASRY, K et al.Angiogenesis (London). 2011, Vol 14, Num 2, pp 155-161, issn 0969-6970, 7 p.Article

Prognostic significance of human epididymis protein 4 in epithelial ovarian cancerPAEK, Jiheum; LEE, San-Hui; YIM, Ga-Won et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 158, Num 2, pp 338-342, issn 0301-2115, 5 p.Article

Identification of aberrant promoter hypomethylation of HOXA10 in ovarian cancerWENJUN CHENG; YI JIANG; CUIXIA LIU et al.Journal of cancer research and clinical oncology. 2010, Vol 136, Num 8, pp 1221-1227, issn 0171-5216, 7 p.Article

Thrombocytosis in Advanced Epithelial Ovarian CancerSOONTHORNTHUM, Tanomsiri; SURASERANEEWONG, Veera; KENGSAKOL, Karun et al.Chot Mai Het Thang Phaet. 2007, Vol 90, Num 8, pp 1495-1500, issn 0125-2208, 6 p.Article

Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer : A single institution experienceBOZAS, George; DIMOPOULOS, Meletios A; PAPADIMITRIOU, Christos et al.Oncology. 2006, Vol 70, Num 4, pp 265-272, issn 0030-2414, 8 p.Article

Clinical management of epithelial ovarian cancer during pregnancyGRIMM, Donata; WOELBER, Linn; TRILLSCH, Fabian et al.European journal of cancer (1990). 2014, Vol 50, Num 5, pp 963-971, issn 0959-8049, 9 p.Article

Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patientsBIGNOTTI, Eliana; TODESCHINI, Paola; TOGNON, Germana et al.European journal of cancer (1990). 2010, Vol 46, Num 5, pp 944-953, issn 0959-8049, 10 p.Article

Epithelial Ovarian Cancer in Greece : A Retrospective Study of 1,791 Patients by the Hellenic Cooperative Oncology Group (HeCOG)PECTASIDES, D; PAPAXOINIS, G; SKARLOS, D. V et al.Anticancer research. 2009, Vol 29, Num 2, pp 745-751, issn 0250-7005, 7 p.Article

A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancerYILDIZ, Ibrahim; TAS, Faruk; YASASEVER, Vildan et al.Cancer chemotherapy and pharmacology. 2013, Vol 72, Num 2, pp 437-444, issn 0344-5704, 8 p.Article

Comparison of the efficacy of low anterior resection with primary anastomosis and Hartmann's procedure in advanced primary or recurrent epithelial ovarian cancerHEE SEUNG KIM; EUN NA KIM; KANG, Soon-Beom et al.European journal of obstetrics, gynecology, and reproductive biology. 2011, Vol 156, Num 2, pp 194-198, issn 0301-2115, 5 p.Article

Assessing the Impact of Polysomy-17 on HER2 Status and the Correlations of HER2 Status With Prognostic Variables (ER, PR, p53, Ki-67) in Epithelial Ovarian Cancer: A Tissue Microarray Study Using Immunohistochemistry and Fluorescent In Situ HybridizationLIN, Chih-Kuang; LIN, Wea-Lung; CHEN, Fong-Lin et al.International journal of gynecological pathology. 2011, Vol 30, Num 4, pp 372-379, issn 0277-1691, 8 p.Article

Assessment of preoperative serum prolidase activity in epithelial ovarian cancerCAMUZCUOGLU, Hakan; ARIOZ, Dagistan Tolga; TOY, Harun et al.European journal of obstetrics, gynecology, and reproductive biology. 2009, Vol 147, Num 1, pp 97-100, issn 0301-2115, 4 p.Article

The transcription factor Sox11 is a prognostic factor for improved recurrence-free survival in epithelial ovarian cancerBRENNAN, Donal J; EK, Sara; JIRSTROM, Karin et al.European journal of cancer (1990). 2009, Vol 45, Num 8, pp 1510-1517, issn 0959-8049, 8 p.Article

Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancerHATA, Kohkichi; DIPOK KUMAR DHAR; WATANABE, Yoh et al.European journal of cancer (1990). 2007, Vol 43, Num 9, pp 1452-1459, issn 0959-8049, 8 p.Article

Solitary parenchymal splenic recurrence of ovarian adenocarcinoma : A case report and review of the literatureTSERKEZOGLOU, Aliki; KONTOU, Sofia; HATJIELEFTHERIOU, George et al.Anticancer research. 2005, Vol 25, Num 2B, pp 1471-1476, issn 0250-7005, 6 p.Article

The treatment and outcomes of early-stage epithelial ovarian cancer : have we made any progress?CHAN, J. K; FUH, K; SHIN, J. Y et al.British journal of cancer. 2008, Vol 98, Num 7, pp 1191-1196, issn 0007-0920, 6 p.Article

Discrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profilingOUELLET, Véronique; PROVENCHER, Diane M; MES-MASSON, Anne-Marie et al.Oncogene (Basingstoke). 2005, Vol 24, Num 29, pp 4672-4687, issn 0950-9232, 16 p.Article

Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancerGABRIEL, Boris; MILDENBERGER, Stephan; WEISSER, Christian W et al.Anticancer research. 2004, Vol 24, Num 2B, pp 921-927, issn 0250-7005, 7 p.Article

Serum endostatin levels in patients with epithelial ovarian cancerHATA, Kohkichi; DIPOK KUMAR DHAR; KANASAKI, Haruhiko et al.Anticancer research. 2003, Vol 23, Num 2C, pp 1907-1912, issn 0250-7005, 6 p.Article

Maintenance therapy in epithelial ovarian cancer: from chemotherapy to targeted agentsFALCI, Cristina; DIECI, Maria Vittoria; GUARNERI, Valentina et al.Expert review of anticancer therapy. 2014, Vol 14, Num 9, pp 1041-1050, issn 1473-7140, 10 p.Article

IGF-II promoter specific methylation and expression in epithelial ovarian cancer and their associations with disease characteristicsBIYUN QIAN; KATSAROS, Dionyssios; LINGENG LU et al.Oncology reports. 2011, Vol 25, Num 1, pp 203-213, issn 1021-335X, 11 p.Article

Predictors of ovarian cancer survival : A population-based prospective study in SwedenLING YANG; KLINT, Asa; LAMBE, Mats et al.International journal of cancer. 2008, Vol 123, Num 3, pp 672-679, issn 0020-7136, 8 p.Article

Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitroHE, X; POOL, M; DARCY, K. M et al.Oncogene (Basingstoke). 2007, Vol 26, Num 34, pp 4961-4968, issn 0950-9232, 8 p.Article

In vitro extreme drug resistance assay to taxanes or platinum compounds for the prediction of clinical outcomes in epithelial ovarian cancer: a prospective cohort studyHEE SEUNG KIM; TAE JOONG KIM; HYUN HOON CHUNG et al.Journal of cancer research and clinical oncology. 2009, Vol 135, Num 11, pp 1513-1520, issn 0171-5216, 8 p.Article

Gemcitabine combined with oxaliplatin (GEMOX) as second-line chemotherapy in patients with advanced ovarian cancer refractory or resistant to platinum and taxane: A multicentric feasibility studyRASPAGLIESI, Francesco; ZANABONI, Flavia; SCIBILIA, Giuseppe et al.Oncology. 2004, Vol 67, Num 5-6, pp 376-381, issn 0030-2414, 6 p.Article